title2

Scientific Papers and Presentations

The references below are a representative sample of recent scientific publications and presentations authored/edited by CRC principals. Please contact us for information on how to obtain reprints or for further information.

Alvarez XA, Corzo L, Laredo M, Sampedro C, Cacabelos R, Windisch M, Moessler H,  Crook TH.  2005. Neuropeptide Dietry Supplement N-PEP-12 Enhances Cognitive Function and Activates Brain Bioelectrical Activity in Healthy Elderly Subjects. Methods and Findings in Experimental and Clinical Pharmacology; 27: 483-487.

Crook T. The role of phosphatidylserine in preventing dementia following stroke. Paper presented at The 10th National Symposium on Heart and Brain, Jakarta, Indonesia, October, 2009.

Crook TH, Ferris SH, Laredo X, Alvarez A, Moessler H. 2005. Effects of N-PEP-12 on memory among older adults. International Clinical Psychopharmacology; 20: 97-100.

Crook T, Kay G.  Assessing the potential of drugs to improve cognition in humans. Paper presented at the 13th Annual Canine Cognition Conference, Toronto, Canada, June, 2007.

Crook T, Kay G.  2009. Overactive bladder medicine and precise cognitive testing. The International Journal of Clinical Practice; 63: 516.

Crook TH, Kay G. Assessing the Potential of Drugs to Improve Cognition in Humans. In Press.

Crook TH, Kay G, Larrabee G. Computer Based Cognitive Testing. In I. Grant & K.M. Adams (Eds.), Neuropsychological Assessment of Neuropsychiatric Disorders, Third Edition). New York: Oxford University Press, 2009.

Ferris S, Schneider L, Farmer M, Kay G, Crook T.  2007. A double-blind, placebo-controlled trial of memantine in age-associated memory impairment (memantine in AAMI).  Int J Geriatr Psychiatry; 22: 448-455.

Kay GG, Crook TH. 2009. Neuropsychological Evaluation of Age-Related Cognitive Impairment. Aviation, Space and Environmental Medicine; 80, 3: 236.

Kay G, Crook T. Differential Effects of the Antimuscarinic Agents Tolterodine Tartrate ER and Oxybutynin Chloride ER on Recent Memory in Older Subjects. Paper presented at 36th Annual Meeting of the International Continence Society, Christchurch, New Zealand, November, 2006.

Kay G, Crook T, Rekeda L, Lima R, Ebinger U, Arguinzoniz M, Steel M. 2006. Differential Effects of the Antimuscarinic Agents Darifenacin and Oxybutynin ER on Memory in Older Subjects. Eur Urol;  50: 317-326.

Kay G, Crook T, Rekeda L, Lima R, Steel M. Differential effects of darifenacin and extended-release oxybutin on memory function in older subjects. Paper presented at German Urology Society, Hamburg, Germany, September 2006.

Kay, G. G., & Logan, B. K., (2011). Drugged Driving Expert Panel Report: A consensus protocol for assessing the potential of drugs to impair driving. (DOT HS 811 438). Washington, DC: National Highway Traffic Safety Administration.

Kay GG, Michaels MA, Pakull B. 2009. Simulated Driving Changes in Young Adults with ADHD Receiving Mixed Amphetamine Salts Extended Release and Atomoxetine. J Atten Disord; 12:316-329.

Packham C, Kay G, (June 21, 2013). Drug-Impaired Driving: Test Without Crashing. Interview With Gary G. Kay, PhD, on Driving Simulation.